Vitamin D analogs and coactivators

Anticancer Research

Volumn 26, Issue 4 A, 2006, Pages 2717-2721

  Eelen, Guy ^a   Verlinden, Lieve ^a   De Clercq, Pierre ^b   Vandewalle, Maurits ^b   Bouillon, Roger ^a,c   Verstuyf, Annemieke ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

^c Onderwijs en Navorsing   (Belgium)

Author keywords

Analogs; Antiproliferative effects; Coactivators; Review; Vitamin D

Indexed keywords

1,3,24 TRIHYDROXY 26,27 CYCLO 9,10 SECOCHOLESTA 5,7,10(19),22 TETRAENE 25 CARBOXYLIC ACID BUTYL ESTER; 19 NOR 14 EPI 23 YNE 1,25 DIHYDROXYVITAMIN D3; 19 NOR 14,20 BISEPI 23 YNE 1,25 DIHYDROXYVITAMIN D3; 20 EPICALCITRIOL; 9,11 BISNOR 16A HOMO 20 EPI 1,25 DIHYDROXYVITAMIN D3; BL 314; CALCIPOTRIOL; CALCITRIOL; CALCITRIOL DERIVATIVE; LEXACALCITOL; NUCLEAR RECEPTOR COACTIVATOR 2; PROTEIN P300; PROTEIN P60; RECEPTOR PROTEIN; RO 24 5531; STEROID RECEPTOR COACTIVATOR 1; TX 522; TX 527; UNCLASSIFIED DRUG; VITAMIN D RECEPTOR; VITAMIN D RECEPTOR INTERACTING PROTEIN 205;

CANCER INHIBITION; CELL PROLIFERATION; DRUG DESIGN; DRUG MECHANISM; DRUG POTENCY; DRUG RECEPTOR BINDING; GENETIC TRANSCRIPTION; HUMAN; HYPERCALCEMIA; HYPERCALCIURIA; OSTEOLYSIS; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; STRUCTURE ACTIVITY RELATION;

ACETYLTRANSFERASES; CALCITRIOL; CARRIER PROTEINS; HISTONE ACETYLTRANSFERASES; HUMANS; NERVE TISSUE PROTEINS; NUCLEAR RECEPTOR COACTIVATOR 2; P300-CBP TRANSCRIPTION FACTORS; RECEPTORS, CALCITRIOL; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 33746641415     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (28)

1. Bouillon R, Okamura WH and Norman AW: Structure-function relationships in the vitamin D endocrine system. Endocr Rev 16: 200-257, 1995.
2. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schutz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P and Evans RM: The nuclear receptor superfamily: the second decade. Cell 83: 835-839, 1995.
3. Sone T, Ozono K and Pike JW: A 55-kilodalton accessory factor facilitates vitamin D receptor DNA binding. Mol Endocrinol 5: 1578-1586, 1991.
4. 3 signalling. Nature 355: 446-449, 1992.
5. Carlberg C, Bendik I, Wyss A, Meier E, Sturzenbecker LJ, Grippo JF and Hunziker W: Two nuclear signalling pathways for vitamin D. Nature 361: 657-660, 1993.
6. Kimmel-Jehan C, Darwish HM, Strugnell SA, Jehan F, Wiefling B and DeLuca HF: DNA bending is induced by binding of vitamin D receptor-retinoid X receptor heterodimers to vitamin D response elements. J Cell Biochem 74: 220-228, 1999.
7. Rachez C and Freedman LP: Mechanisms of gene regulation by vitamin D(3) receptor: a network of coactivator interactions. Gene 246: 9-21, 2000.
8. Rachez C, Gamble M, Chang CP, Atkins GB, Lazar MA and Freedman LP: The DRIP complex and SRC-1/P160 coactivators share similar nuclear receptor binding determinants but constitute functionally distinct complexes. Mol Cell Biol 20: 2718-2726, 2000.
9. Burakov D, Crofts LA, Chang CP and Freedman LP: Reciprocal recruitment of DRIP/mediator and p160 coactivator complexes in vivo by estrogen receptor. J Biol Chem 277:14359-14362, 2000.
10. Sharma D and Fondell JD: Ordered recruitment of histone acetyltransferases and the TRAP/mediator complex to thyroid hormone-responsive promoters in vivo. Proc Natl Acad Sci USA 99: 7934-7939, 2002.
11. 3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts. J Bone Miner Res 20(2): 305-317, 2005.
12. Kitagawa H, Fujiki R, Yoshimura K, Mezaki Y, Uematsu Y, Matsui D, Ogawa S, Unno K, Okubo M, Tokita A, Nakagawa T, Ito T, Ishimi Y, Nagasawa H, Matsumoto T, Yanagisawa J and Kato S: The chromatin-remodeling complex WINAC targets a nuclear receptor to promoters and is impaired in Williams syndrome. Cell 773: 905-917, 2003.
13. Auboeuf D, Honig A, Berget SM and O'Malley BW: Coordinate regulation of transcription and splicing by steroid receptor coregulators. Science 298: 416-419, 2002.
14. Barry JB, Leong GM, Church WB, Issa LL, Eisman JA and Gardiner EM: Interactions of SKIP/NCoA-62, TFIIB, and retinoid X receptor with vitamin D receptor helix H10 residues. J Biol Chem 275: 8224-8228, 2003.
15. MacDonald PN, Sherman DR, Dowd DR, Jefcoat SC Jr and DeLisle RK: The vitamin D receptor interacts with general transcription factor IIB. J Biol Chem 270: 4748-4752, 1995.
16. Kurihara N, Reddy SV, Araki N, Ishizuka S, Ozono K, Cornish J, Cundy T, Singer FR and Roodman GD: Role of TAFII-17, a VDR binding protein, in the increased osteoclast formation in Paget's disease. J Bone Miner Res 19: 1154-1164, 2004.
17. Savkur RS, Bramlett KS, Stayrook K R, Nagpal S and Burris T P: Coactivation of the human vitamin D receptor by the peroxisome proliferator-activated receptor gamma coactivator-1 alpha. Mol Pharmacol 68(2): 511-517, 2005.
18. 3 inhibit the growth of human breast cancer cells in vitro and in vivo. Cancer Res 60: 2673-2679, 2000.
19. 3 responsive elements. J Bone Miner Res 76: 625-638, 2001.
20. Schuster I, Egger H, Bikle D, Herzig G, Reddy GS, Stuetz A, Stuetz P and Vorisek G: Selective inhibition of vitamin D hydroxylases in human keratinocytes. Steroids 66: 409-422, 2001.
21. Schuster I, Egger H, Astecker N, Herzig G, Schussler M and Vorisek G: Selective inhibitors of CYP24: mechanistic tools to explore vitamin D metabolism in human keratinocytes. Steroids 66: 451-462, 2001.
22. Eelen G, Verlinden L, Rochel N, Claessens F, De Clercq P, Vandewalle M, Tocchini-Valentini G, Moras D, Bouillon R and Verstuyf A: Superagonistic action of 14-epi-analogs of 1,25-dihydroxyvitamin D explained by vitamin D receptor-coactivator interaction. Mol Pharmacol 67(5): 1566-1573, 2005.
23. 3 potently stimulates gene-specific DNA binding of the vitamin D receptor in osteoblasts. J Biol Chem 278: 31756-31765, 2003.
24. Takeyama K, Masuhiro Y, Fuse H, Endoh H, Murayama A, Kitanaka S, Suzawa M, Yanagisawa J and Kato S: Selective interaction of vitamin D receptor with transcriptional coactivators by a vitamin D analog. Mol Cell Biol 19: 1049-1055, 1999.
25. 3 is mediated by a lack of ligand-induced vitamin D receptor interaction with coactivators. J Biol Chem 275: 16506-16512, 2000.
26. Eelen G, Verlinden L, Van Camp M, Claessens F, De Clercq P, Vandewalle M, Bouillon R and Verstuyf A: Altered vitamin D receptor-coactivator interactions reflect superagonism of vitamin D analogs. J Steroid Biochem Mol Biol [Epub ahead of print], 2005.
27. Rochel N, Wurtz JM, Mitschler A, Klaholz B and Moras D: The crystal structure of the nuclear receptor for vitamin D bound to its natural ligand. Mol Cell 5: 173-179, 2000.
28. Tocchini-Valentini O, Rochel N, Wurtz JM, Mitschler A and Moras D: Crystal structures of the vitamin D receptor complexed to superagonist 20-epi ligands. Proc Natl Acad Sci USA 95: 5491-5496, 2001.